Login / Signup

Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer.

Serkan DegirmenciogluOzgur TanrıverdiAtike Gokcen DemirayHande SenolGamze Gokoz DoguArzu Yaren
Published in: The Journal of international medical research (2019)
The CAPOX regimen is preferred in older patients. Disease progression, metastasis, and mortality rates are higher with FOLFOX than with CAPOX.
Keyphrases
  • metastatic colorectal cancer
  • early stage
  • cross sectional
  • risk factors